繁 简
  • ENG
    • General Outpatient Clinic Public-Private Partnership Programme (GOPC PPP)
    The General Outpatient Clinic Public-Private Partnership Programme (GOPC PPP) is planned to conclude in 2028. Participating patients will be invited to join the Chronic Disease Co-care Pilot Scheme (CDCC) and continue to receive comprehensive care from family doctor in the community.

    Download

    e-Bulletin

    Issue 16 - GOPC PPP List of Specified Drugs Updates

    24-12-2018
    Dear Doctors,

    We are pleased to inform you that the List of Specified Drugs will be updated on 28 January 2019. Three new drugs are added including Felodipine Extended Release Tablet, Atorvastatin (Calcium) Tablet and Ammonia and Ipecacuanha Mixture. You can refer to the Appendix for details.

    Please be reminded that the supply of anti-hypertensive drug, Adalat Retard 20mg (Nifedipine SR Tablet 20mg) to Hong Kong will be discontinued in September 2019. Please consider alternative choices of drugs and progressively substitute the drugs for patients.

    Should you have any enquiries regarding the GOPC PPP, please feel free to contact us at gopcppp@ha.org.hk or via the Programme hotline 2300 7300 (after selecting language, press “5” to speak directly with our hotline staff). Thank you for your attention.

    Yours faithfully,
    GOPC PPP Programme Office
    Hospital Authority